Novo CEO pressed by Senate to cut price ranges of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers about the list charges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://kethek.com/